Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemamali Samaratunga

Showing results (91-100 of 187) with videos related to

Pageof 19
Sort By:
Cerebellum (London, England)|February 20, 2019
Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)Olivier J Becherel, Brent L Fogel, Scott I Zeitlin, et al.
Pathology|September 2, 2015
The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancerHemamali Samaratunga, Brett Delahunt, Troy Gianduzzo, et al.
BJU International|August 28, 2009
Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical managementHakan Aydin, Jun Zhang, Hemamali Samaratunga, et al.
BJU International|February 27, 2016
Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012Daniela Danneman, Linda Drevin, Brett Delahunt, et al.
Journal of Kidney Cancer and VHL|March 23, 2017
Multifocal Primary Neoplasms in Kidney Allografts: Evaluation of Two CasesRobert J Ellis, Keng Lim Ng, Hemamali Samaratunga, et al.
Pathology|June 10, 2021
The emerging role of artificial intelligence in the reporting of prostate pathologyLars Egevad, Brett Delahunt, Hemamali Samaratunga, et al.
The Journal of Biological Chemistry|March 1, 2008
Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progressionAndrew J Ramsay, Ying Dong, Melanie L Hunt, et al.
Histopathology|February 28, 2017
UICC drops the ball in the 8th edition TNM staging of urological cancersBrett Delahunt, Lars Egevad, Hemamali Samaratunga, et al.
Biological Chemistry|July 17, 2008
Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)Andrew J Ramsay, Janet C Reid, Mark N Adams, et al.
Human Pathology|May 2, 2017
Genetic profile of ductal adenocarcinoma of the prostateAmanda H Seipel, Thomas Whitington, Brett Delahunt, et al.
Pageof 19

Showing results (91-100 of 187) with videos related to

Sort By:
Pageof 19
Cerebellum (London, England)|February 20, 2019
Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)Olivier J Becherel, Brent L Fogel, Scott I Zeitlin, et al.
Pathology|September 2, 2015
The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancerHemamali Samaratunga, Brett Delahunt, Troy Gianduzzo, et al.
BJU International|August 28, 2009
Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical managementHakan Aydin, Jun Zhang, Hemamali Samaratunga, et al.
BJU International|February 27, 2016
Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012Daniela Danneman, Linda Drevin, Brett Delahunt, et al.
Journal of Kidney Cancer and VHL|March 23, 2017
Multifocal Primary Neoplasms in Kidney Allografts: Evaluation of Two CasesRobert J Ellis, Keng Lim Ng, Hemamali Samaratunga, et al.
Pathology|June 10, 2021
The emerging role of artificial intelligence in the reporting of prostate pathologyLars Egevad, Brett Delahunt, Hemamali Samaratunga, et al.
The Journal of Biological Chemistry|March 1, 2008
Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progressionAndrew J Ramsay, Ying Dong, Melanie L Hunt, et al.
Histopathology|February 28, 2017
UICC drops the ball in the 8th edition TNM staging of urological cancersBrett Delahunt, Lars Egevad, Hemamali Samaratunga, et al.
Biological Chemistry|July 17, 2008
Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)Andrew J Ramsay, Janet C Reid, Mark N Adams, et al.
Human Pathology|May 2, 2017
Genetic profile of ductal adenocarcinoma of the prostateAmanda H Seipel, Thomas Whitington, Brett Delahunt, et al.
Pageof 19